{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?page=23&sponsor=Boehringer+Ingelheim", "query": { "sponsor": "Boehringer Ingelheim", "page": 23 }, "page_size": 10 }, "pagination": { "page": 23, "page_size": 10, "total_count": 673, "total_pages": 68, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=24&sponsor=Boehringer+Ingelheim&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?page=22&sponsor=Boehringer+Ingelheim&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-16T07:20:05.319Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00385671", "title": "An Open-Label Comparison of Duloxetine to Other Alternatives for the Management of Diabetic Peripheral Neuropathic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetic Neuropathy, Painful" ], "interventions": [ { "name": "duloxetine hydrochloride", "type": "DRUG" }, { "name": "pregabalin", "type": "DRUG" }, { "name": "gabapentin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Eli Lilly and Company", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 407, "start_date": "2006-09", "completion_date": "2009-11", "has_results": true, "last_update_posted_date": "2011-07-26", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 5, "location_summary": "Torrance, California • Cromwell, Connecticut • Staten Island, New York + 2 more", "locations": [ { "city": "Torrance", "state": "California" }, { "city": "Cromwell", "state": "Connecticut" }, { "city": "Staten Island", "state": "New York" }, { "city": "Greenville", "state": "North Carolina" }, { "city": "Midvale", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT00385671" }, { "nct_id": "NCT02850965", "title": "Efficacy, Safety and Immunogenicity of BI 695501 Versus Humira® in Patients With Moderate to Severe Chronic Plaque Psoriasis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Psoriasis" ], "interventions": [ { "name": "BI 695501", "type": "DRUG" }, { "name": "Humira", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 318, "start_date": "2016-08-17", "completion_date": "2018-01-17", "has_results": true, "last_update_posted_date": "2019-02-08", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 14, "location_summary": "Anniston, Alabama • Phoenix, Arizona • Santa Ana, California + 11 more", "locations": [ { "city": "Anniston", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Santa Ana", "state": "California" }, { "city": "DeLand", "state": "Florida" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02850965" }, { "nct_id": "NCT01897532", "title": "Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Diabetes Mellitus, Type 2" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Linagliptin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 6991, "start_date": "2013-07-10", "completion_date": "2018-01-18", "has_results": true, "last_update_posted_date": "2019-04-04", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 197, "location_summary": "Huntsville, Alabama • Scottsboro, Alabama • Tuscumbia, Alabama + 150 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Scottsboro", "state": "Alabama" }, { "city": "Tuscumbia", "state": "Alabama" }, { "city": "Glendale", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01897532" }, { "nct_id": "NCT07497087", "title": "A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Systemic Sclerosis" ], "interventions": [ { "name": "Placebo matching nerandomilast formulation 1", "type": "DRUG" }, { "name": "Placebo matching nerandomilast formulation 2", "type": "DRUG" }, { "name": "Nerandomilast formulation 1", "type": "DRUG" }, { "name": "Nerandomilast formulation 2", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 448, "start_date": "2026-07-27", "completion_date": "2030-03-17", "has_results": false, "last_update_posted_date": "2026-10-14", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 30, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Scottsdale, Arizona + 23 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Scottsdale", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07497087" }, { "nct_id": "NCT01523587", "title": "LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Carcinoma, Non-Small-Cell Lung" ], "interventions": [ { "name": "afatinib", "type": "DRUG" }, { "name": "erlotinib", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 795, "start_date": "2012-03-05", "completion_date": "2017-12-27", "has_results": true, "last_update_posted_date": "2019-02-15", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 33, "location_summary": "Chandler, Arizona • La Jolla, California • Sacramento, California + 27 more", "locations": [ { "city": "Chandler", "state": "Arizona" }, { "city": "La Jolla", "state": "California" }, { "city": "Sacramento", "state": "California" }, { "city": "Boca Raton", "state": "Florida" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT01523587" }, { "nct_id": "NCT05990738", "title": "DAREON™-9: A Study to Test How Well Different Doses of BI 764532 Are Tolerated by People With Small Cell Lung Cancer When Taken Together With a Single Agent Chemotherapy", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Small Cell Lung Carcinoma (SCLC)" ], "interventions": [ { "name": "BI 764532", "type": "DRUG" }, { "name": "Topotecan", "type": "DRUG" }, { "name": "Single agent chemotherapy", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 69, "start_date": "2024-02-14", "completion_date": "2027-04-30", "has_results": false, "last_update_posted_date": "2026-09-15", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 4, "location_summary": "Washington D.C., District of Columbia • Jacksonville, Florida • Miami, Florida + 1 more", "locations": [ { "city": "Washington D.C.", "state": "District of Columbia" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Miami", "state": "Florida" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05990738" }, { "nct_id": "NCT00431067", "title": "Phase II Trial of BIBW 2992 in Patients With HER2-positive Metastatic Breast Cancer After Failure of Trastuzumab Therapy", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Breast Neoplasms" ], "interventions": [ { "name": "BIBW 2992", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 41, "start_date": "2006-09", "completion_date": null, "has_results": true, "last_update_posted_date": "2014-06-09", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 6, "location_summary": "Scottsdale, Arizona • Encinitas, California • Santa Monica, California + 3 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Santa Monica", "state": "California" }, { "city": "Tampa", "state": "Florida" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00431067" }, { "nct_id": "NCT02573311", "title": "Actual Use Study of Tamsulosin in Men", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Urological Manifestations" ], "interventions": [ { "name": "tamsulosin hydrochloride", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "MALE", "summary": "18 Years and older · Male only" }, "enrollment_count": 1117, "start_date": "2015-09-23", "completion_date": "2016-08-01", "has_results": true, "last_update_posted_date": "2020-04-08", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 40, "location_summary": "Birmingham, Alabama • Homewood, Alabama • Hoover, Alabama + 35 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Homewood", "state": "Alabama" }, { "city": "Hoover", "state": "Alabama" }, { "city": "McCalla", "state": "Alabama" }, { "city": "Pinson", "state": "Alabama" } ], "official_url": "https://clinicaltrials.gov/study/NCT02573311" }, { "nct_id": "NCT06082843", "title": "A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hypertension, Portal", "Liver Cirrhosis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Avenciguat", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 22, "start_date": "2024-01-03", "completion_date": "2024-05-30", "has_results": true, "last_update_posted_date": "2025-06-12", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 2, "location_summary": "Pasadena, California • Rialto, California", "locations": [ { "city": "Pasadena", "state": "California" }, { "city": "Rialto", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06082843" }, { "nct_id": "NCT00002418", "title": "The Safety and Effectiveness of Didanosine Plus Stavudine Plus Nevirapine Combined With MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "HIV Infections" ], "interventions": [ { "name": "Emivirine", "type": "DRUG" }, { "name": "Hydroxyurea", "type": "DRUG" }, { "name": "Nevirapine", "type": "DRUG" }, { "name": "Stavudine", "type": "DRUG" }, { "name": "Didanosine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 25, "start_date": null, "completion_date": null, "has_results": false, "last_update_posted_date": "2008-08-14", "last_synced_at": "2026-10-16T07:20:05.319Z", "location_count": 5, "location_summary": "Beverly Hills, California • Denver, Colorado • Atlanta, Georgia + 2 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Providence", "state": "Rhode Island" }, { "city": "Hampton", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT00002418" } ] }